Nagao, Y.; Amo-Shiinoki, K.; Nakabayashi, H.; Hatanaka, M.; Kondo, M.; Matsunaga, K.; Emoto, M.; Okuya, S.; Tanizawa, Y.; Tanabe, K.
Gsk-3-Mediated Proteasomal Degradation of ATF4 Is a Proapoptotic Mechanism in Mouse Pancreatic β-Cells. Int. J. Mol. Sci. 2022, 23, 13586.
https://doi.org/10.3390/ijms232113586
AMA Style
Nagao Y, Amo-Shiinoki K, Nakabayashi H, Hatanaka M, Kondo M, Matsunaga K, Emoto M, Okuya S, Tanizawa Y, Tanabe K.
Gsk-3-Mediated Proteasomal Degradation of ATF4 Is a Proapoptotic Mechanism in Mouse Pancreatic β-Cells. International Journal of Molecular Sciences. 2022; 23(21):13586.
https://doi.org/10.3390/ijms232113586
Chicago/Turabian Style
Nagao, Yuko, Kikuko Amo-Shiinoki, Hiroko Nakabayashi, Masayuki Hatanaka, Manabu Kondo, Kimie Matsunaga, Masahiro Emoto, Shigeru Okuya, Yukio Tanizawa, and Katsuya Tanabe.
2022. "Gsk-3-Mediated Proteasomal Degradation of ATF4 Is a Proapoptotic Mechanism in Mouse Pancreatic β-Cells" International Journal of Molecular Sciences 23, no. 21: 13586.
https://doi.org/10.3390/ijms232113586
APA Style
Nagao, Y., Amo-Shiinoki, K., Nakabayashi, H., Hatanaka, M., Kondo, M., Matsunaga, K., Emoto, M., Okuya, S., Tanizawa, Y., & Tanabe, K.
(2022). Gsk-3-Mediated Proteasomal Degradation of ATF4 Is a Proapoptotic Mechanism in Mouse Pancreatic β-Cells. International Journal of Molecular Sciences, 23(21), 13586.
https://doi.org/10.3390/ijms232113586